Stock ATOS ATOSSA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Atossa Therapeutics, Inc.

Equities

ATOS

US04962H5063

Market Closed - Nasdaq
Other stock markets
 21:00:00 28/06/2024 BST 		5-day change 1st Jan Change
1.19 USD +4.39% Intraday chart for Atossa Therapeutics, Inc. +5.31% +35.23%
06-28 Atossa Therapeutics Doubles Z-Endoxifen Dose in Phase 2 Breast Cancer Study MT
06-28 Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ATOSSA THERAPEUTICS, INC.
Other Biotechnology & Medical Research
+4.39%+5.31%+35.23%+1.71%-53.33% 150M
Bearish
Neutral
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ATOS Stock
  4. Charts Atossa Therapeutics, Inc.
  5. Comparison Chart